Fluorouracil nur Creme (L01BC02)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter KKH) aims to conclude discount contracts pursuant to § 130a paragraph 8 SGB V with all suitable pharmaceutical companies for the active substance named under BT-21 lot (ATC) and, if applicable, restricted to certain dosage forms within the framework of a so-called "Open-House procedure." Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a discount agreement pursuant to § 130a para. 8 SGB V for the aforementioned active substance. Interested pharmaceutical companies can request the participation documents as well as the contract at the stated contact address. A prerequisite for concluding a contract is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. A contract is concluded with every pharmaceutical company that meets the participation requirements. Exclusivity is not granted. Accession or contract conclusion can take place at any time and under the same conditions. Individual contract…

TENDER BRIEF

TENDER DOCUMENTS